The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 21, 2024

Filed:

Mar. 18, 2021
Applicant:

Cara Therapeutics, Inc., Stamford, CT (US);

Inventors:

Bryan R. Wilson, Brewster, NY (US);

Stephen J. O'Connor, Guilford, CT (US);

Assignee:

Cara Therapeutics, Inc., Stamford, CT (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/07 (2006.01); A61K 9/16 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 31/40 (2006.01); A61K 31/485 (2006.01);
U.S. Cl.
CPC ...
A61K 38/07 (2013.01); A61K 9/1617 (2013.01); A61K 9/1623 (2013.01); A61K 9/1694 (2013.01); A61K 9/4808 (2013.01); A61K 9/5089 (2013.01); A61K 31/40 (2013.01); A61K 31/485 (2013.01);
Abstract

The invention provides formulations for oral delivery of a therapeutic agent wherein the formulation comprises a kappa opioid receptor agonist, an oligosaccharide stabilizing agent and an optional absorption enhancer. The kappa opioid receptor agonist may be coated with, embedded in or mixed with an oligosaccharide, such as trehalose. Also provided are capsules containing the oral formulations of the kappa opioid receptor agonists, the oligosaccharide and the absorption enhancer of the invention. The invention further provides methods of manufacture of the formulations and methods of their use for the prophylaxis, inhibition and treatment of variety of kappa opioid receptor-associated diseases and conditions such as pain, pruritus and inflammation. The methods of use include administering to the mammal the formulation of the kappa opioid receptor agonist, oligosaccharide and optional absorption enhancers.


Find Patent Forward Citations

Loading…